You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults
- Disease
- intraabdominal infection
- Drug Name
- CAZ-104
- Generic Name
- CAZ-AVI
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- IIIa
- Start Date
- Mar 22, 2012
- Study Name
- D4280C00001
- Study Id
- D4280C00001
- ClinicalTrials.gov ID
- NCT01499290
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
